Pliant Therapeutics (PLRX) Change in Account Payables (2019 - 2026)
Pliant Therapeutics (PLRX) reported Change in Account Payables of -$118000.0 for Q1 2026, up 65.09% year-over-year from -$71476.7 in Q1 2025, and down 3833.33% quarter-over-quarter from -$3000.0 in Q4 2025.
Pliant Therapeutics (PLRX) Change in Account Payables (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 8 years of Change in Account Payables data on file, last reported at -$118000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$118000.0, up 65.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.3 million (down 350.73% YoY), and the FY2025 annual result was -$5.5 million, down 483.75% from the prior year.
- Change in Account Payables fell to -$118000.0 in Q1 2026 per PLRX's latest filing, from -$3000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.7 million in Q3 2024 and troughed at -$4.2 million in Q2 2025.
- A 5-year average of -$150117.6 and a median of -$118000.0 in 2026 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables plunged 2163.16% in 2022, then jumped 1936.54% in 2023.
- A 5-year view of Change in Account Payables shows it stood at -$1.6 million in 2022, then soared by 173.02% to $1.2 million in 2023, then slumped by 179.35% to -$930000.0 in 2024, then surged by 99.68% to -$3000.0 in 2025, then sank by 3833.33% to -$118000.0 in 2026.
- Business Quant data shows PLRX's Change in Account Payables at -$118000.0 in Q1 2026, -$3000.0 in Q4 2025, and -$897000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -9.42 Mn |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | -118,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118,000.00 |
| Mar 31, 2026 | -118,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Sep 30, 2025 | -897,000.00 |
| Sep 30, 2025 | -897,000.00 |
| Jun 30, 2025 | -4.24 Mn |
| Jun 30, 2025 | -4.24 Mn |
| Mar 31, 2025 | -338,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Dec 31, 2024 | -930,000.00 |
| Dec 31, 2024 | -930,000.00 |
| Sep 30, 2024 | 3.73 Mn |
| Sep 30, 2024 | 3.73 Mn |
| Jun 30, 2024 | -3.63 Mn |
| Jun 30, 2024 | -3.63 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |